AAA Analysis – Page 76

Number of deals declines

The number of corporate-backed deals in February was 131, noticeably down from the 174 funding rounds in the same month last year. Investment value, however, increased significantly – up from $5bn in February 2017. The deal count in February declined from the previous month (191 rounds). Total capital invested in corporate-backed rounds in February also… Continue reading Number of deals declines

Analysis: GV exits Flatiron Health

Pharmaceutical firm Roche agreed to acquire cancer research technology provider Flatiron Health, paying $1.9bn for the remainder of the company’s shares, giving GV, the corporate venturing unit of internet conglomerate Alphabet, its fifth latest life sciences exit since November. At the time of the acquisition, Roche already owned a 12.6% stake in Flatiron. The price… Continue reading Analysis: GV exits Flatiron Health

Deal count drops in January

There were 168 corporate-backed deals in January, down from the 199 funding rounds in the same month last year. Investment value, however, increased by 108% to $12.66bn, compared with $6.09bn in January 2017. On a month-on-month basis, the deal count in the first month of this year fell from the 185 rounds worth $13.61bn in… Continue reading Deal count drops in January